RS

Rattan Singh

Active Director Director DIN 06538304
DIN 06538304 First appointment May 2013 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2013
Shareholding value •••• Premium profile

About Rattan Singh

Data last updated:

Rattan Singh is a Director at Bovetas Pharmaceuticals Private Limited (since 2013). The company operates in Chemicals. Bovetas Pharmaceuticals Private Limited reported revenue of ₹45,000 (FY 2019).

DIN 06538304
Primary Designation Director
Industry Chemicals
First Appointment 03 May 2013
Oldest Company Age 13 yrs
Largest company Bovetas Pharmaceuticals Private Limited · ₹45,000 (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 May 20132013₹45,000 (FY 2019)Active

Board colleagues of Rattan Singh

NameDINCompanyDesignation
Sandeep06396370Bovetas Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bovetas Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rattan Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rattan Singh

Rattan Singh currently holds 1 directorship: Bovetas Pharmaceuticals Private Limited (Director, since 03 May 2013, revenue ₹45,000 (FY 2019)).

Rattan Singh was first appointed on 03 May 2013 as Director at Bovetas Pharmaceuticals Private Limited.

The current boards of Rattan Singh's companies include Sandeep (Bovetas Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available